Clinical Trial Update: Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing parnaparin to aspirin for retinal vein occlusion was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Aspirin (Aspirin)
• Parnaparin (parnaparin)

Snippet

Sponsor: Università degli Studi dell'Insubria | Conditions: Retinal Vein Occlusion | Phase 3 | Status: TERMINATED